The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Quest Diagnostics Confirms Investor Day on November 16

Friday, November 09, 2012

Quest Diagnostics Confirms Investor Day on November 1616:13 EST Friday, November 09, 2012MADISON, N.J., Nov. 9, 2012 /PRNewswire/ -- As previously announced, Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, will host an Investor Day on Friday, November 16, 2012 at The Hudson Theatre at the Millennium Broadway Times Square, 145 West 44th Street, New York, NY.  During the event, Quest Diagnostics' new executive leadership team will discuss the company's strategy, performance and plans to drive shareholder value.  In Person AttendanceAdvanced registration is required and attendance will be limited to those who register in advance. To register for the meeting, please go to the following website:http://edge.media-server.com/m/go/registerquestdiagnostics. Check-in will begin at 8:00 a.m. with a continental breakfast. Management presentations will begin promptly at 9:00 a.m. and conclude at 12:30 p.m.Webcast AttendanceA live webcast of the event will be broadcast simultaneously on the Investor Relations page of the Quest Diagnostics website for all interested parties. To access the webcast or a replay of the event, visit: www.QuestDiagnostics.com/investor. The webcast will begin promptly at 9:00 a.m. and conclude at 12:30 p.m.  A replay will be available following the meeting. Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com.Contacts:Kathleen Valentine (Investors): 973-520-2900Wendy Bost (Media): 973-520-2800SOURCE Quest Diagnostics Incorporated